Yang, W., Wei, M., Shen, Y., Huang, C., & Kuo, S. CDK4/6 inhibitors synergize with radiotherapy to prime the tumor microenvironment and enhance the antitumor effect of anti-PD-L1 immunotherapy in triple-negative breast cancer. BMC.
Chicago Style (17th ed.) CitationYang, Wen-Chi, Ming-Feng Wei, Ying-Chun Shen, Chiun-Sheng Huang, and Sung-Hsin Kuo. CDK4/6 Inhibitors Synergize with Radiotherapy to Prime the Tumor Microenvironment and Enhance the Antitumor Effect of Anti-PD-L1 Immunotherapy in Triple-negative Breast Cancer. BMC.
MLA (9th ed.) CitationYang, Wen-Chi, et al. CDK4/6 Inhibitors Synergize with Radiotherapy to Prime the Tumor Microenvironment and Enhance the Antitumor Effect of Anti-PD-L1 Immunotherapy in Triple-negative Breast Cancer. BMC.
Warning: These citations may not always be 100% accurate.